chemotherapy: be administered in cycles

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents treatment
Weight: 0.64
, regimen
Weight: 0.62
, modality
Weight: 0.61
, agent
Weight: 0.60
, prostate cancer
Weight: 0.59
Siblings gene therapy
Weight: 0.66
, breast cancer
Weight: 0.36
, dialysis
Weight: 0.36
, transplant
Weight: 0.34
, mastectomy
Weight: 0.34

Related properties

Property Similarity
be administered in cycles 1.00
be administered 0.88
is administered 0.88
be given in cycles 0.88
be administered to patient 0.82

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Remarkability exclusitivity between siblings

0.08
Rule weight: 0.13
Evidence weight: 0.73
Similarity weight: 0.82
Evidence: 0.34
¬ Remarkable(chemotherapy, be administered in cycles) ⋁
Evidence: 0.81
¬ Remarkable(gene therapy, be administered to patient)

Remarkability from sibling implausibility

0.46
Rule weight: 0.60
Evidence weight: 0.94
Similarity weight: 0.82
Evidence: 0.14
Plausible(chemotherapy, be administered in cycles) ⋁
Evidence: 0.81
Remarkable(gene therapy, be administered to patient) ⋁
Evidence: 0.38
¬ Plausible(gene therapy, be administered to patient)

Salient implies Plausible

0.23
Rule weight: 0.28
Evidence weight: 0.83
Similarity weight: 1.00
Evidence: 0.14
Plausible(chemotherapy, be administered in cycles) ⋁
Evidence: 0.20
¬ Salient(chemotherapy, be administered in cycles)

Similarity expansion

0.73
Rule weight: 0.85
Evidence weight: 0.97
Similarity weight: 0.88
Evidence: 0.20
Typical(chemotherapy, be administered in cycles) ⋁
Evidence: 0.04
¬ Typical(chemotherapy, is administered)
0.72
Rule weight: 0.85
Evidence weight: 0.95
Similarity weight: 0.88
Evidence: 0.20
Typical(chemotherapy, be administered in cycles) ⋁
Evidence: 0.07
¬ Typical(chemotherapy, be administered)
0.62
Rule weight: 0.85
Evidence weight: 0.83
Similarity weight: 0.88
Evidence: 0.20
Typical(chemotherapy, be administered in cycles) ⋁
Evidence: 0.22
¬ Typical(chemotherapy, be given in cycles)
0.62
Rule weight: 0.85
Evidence weight: 0.82
Similarity weight: 0.88
Evidence: 0.14
Plausible(chemotherapy, be administered in cycles) ⋁
Evidence: 0.21
¬ Plausible(chemotherapy, be administered)
0.61
Rule weight: 0.85
Evidence weight: 0.81
Similarity weight: 0.88
Evidence: 0.14
Plausible(chemotherapy, be administered in cycles) ⋁
Evidence: 0.22
¬ Plausible(chemotherapy, is administered)
0.59
Rule weight: 0.85
Evidence weight: 0.79
Similarity weight: 0.88
Evidence: 0.14
Plausible(chemotherapy, be administered in cycles) ⋁
Evidence: 0.25
¬ Plausible(chemotherapy, be given in cycles)
0.56
Rule weight: 0.85
Evidence weight: 0.75
Similarity weight: 0.88
Evidence: 0.20
Salient(chemotherapy, be administered in cycles) ⋁
Evidence: 0.31
¬ Salient(chemotherapy, be given in cycles)
0.52
Rule weight: 0.85
Evidence weight: 0.70
Similarity weight: 0.88
Evidence: 0.20
Salient(chemotherapy, be administered in cycles) ⋁
Evidence: 0.38
¬ Salient(chemotherapy, be administered)
0.48
Rule weight: 0.85
Evidence weight: 0.64
Similarity weight: 0.88
Evidence: 0.20
Salient(chemotherapy, be administered in cycles) ⋁
Evidence: 0.46
¬ Salient(chemotherapy, is administered)
0.45
Rule weight: 0.85
Evidence weight: 0.60
Similarity weight: 0.88
Evidence: 0.34
Remarkable(chemotherapy, be administered in cycles) ⋁
Evidence: 0.60
¬ Remarkable(chemotherapy, be given in cycles)
0.32
Rule weight: 0.85
Evidence weight: 0.42
Similarity weight: 0.88
Evidence: 0.34
Remarkable(chemotherapy, be administered in cycles) ⋁
Evidence: 0.87
¬ Remarkable(chemotherapy, be administered)
0.28
Rule weight: 0.85
Evidence weight: 0.37
Similarity weight: 0.88
Evidence: 0.34
Remarkable(chemotherapy, be administered in cycles) ⋁
Evidence: 0.95
¬ Remarkable(chemotherapy, is administered)

Typical and Remarkable implies Salient

0.13
Rule weight: 0.14
Evidence weight: 0.95
Similarity weight: 1.00
Evidence: 0.20
Salient(chemotherapy, be administered in cycles) ⋁
Evidence: 0.20
¬ Typical(chemotherapy, be administered in cycles) ⋁
Evidence: 0.34
¬ Remarkable(chemotherapy, be administered in cycles)

Typical implies Plausible

0.40
Rule weight: 0.48
Evidence weight: 0.83
Similarity weight: 1.00
Evidence: 0.14
Plausible(chemotherapy, be administered in cycles) ⋁
Evidence: 0.20
¬ Typical(chemotherapy, be administered in cycles)

Typicality and Rermarkability incompatibility between siblings

0.10
Rule weight: 0.14
Evidence weight: 0.91
Similarity weight: 0.82
Evidence: 0.34
¬ Remarkable(chemotherapy, be administered in cycles) ⋁
Evidence: 0.27
¬ Typical(gene therapy, be administered to patient)